COVID-19 Supplement #5 for CoVPN Novavax Study

NIH RePORTER · NIH · UM1 · $5,352,745 · view on reporter.nih.gov ↗

Abstract

Saint Louis University (SLU) seeks to expand its service to the Vaccine and Treatment Evaluation Unit (VTEU) network providing resources and expertise to help the network achieve its objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics for COVID-19.

Key facts

NIH application ID: 10301267
Project number: 3UM1AI148685-02S4
Recipient: SAINT LOUIS UNIVERSITY
Principal Investigator: Daniel F. Hoft
Activity code: UM1
Funding institute: NIH
Fiscal year: 2021
Award amount: $5,352,745
Award type: 3
Project period: 2020-12-23 → 2022-11-30